Monthly Archives: August 2017

Best Undervalued Stocks To Invest In 2018

One popular approach to investing based on Benjamin Graham’s methods is to use the so-called “Graham Number.” There are some important differences between the Graham Number and the Graham Formula, but using the Graham Number is definitely useful even if the investor only uses it as a screening tactic.

I have selected the best companies trading below their Graham Number. The companies selected all are suitable for the Defensive Investor or the Enterprising Investor, and have been valued as undervalued based on the ModernGraham valuation model. Further, the overall screen found 28 companies meeting these criteria (out of over 745 companies covered). The full list can be found near the end of this article. To cut down on the length of the post, I have selected 10 stocks trading furthest below their Graham Number.

Defensive Investors are defined as investors who are not able or willing to do substantial research into individual investments, and therefore need to select only the companies that present the least amount of risk. Enterprising Investors, on the other hand, are able to do substantial research and can select companies that present a moderate (though still low) amount of risk. Each company suitable for the Defensive Investor is also suitable for Enterprising Investors.

Best Undervalued Stocks To Invest In 2018: Pershing Gold Corporation(PGLC)

Advisors’ Opinion:

  • [By Sara Cornell]

    Leading the way is CEO Edward Karr. As a founder of Pershing Gold Corp (NASDAQ:PGLC), he currently serves on their Board of Directors, and has been active in the natural resource industry for many years. With a background in finance and investment banking, Karr is credited with raising capital to begin operations at US Gold Corp, and establishing financing for both the operational and exploration sides of the company.

Best Undervalued Stocks To Invest In 2018: Neovasc Inc.(NVCN)

Advisors’ Opinion:

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha) Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX). aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials. Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee. Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday. Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday. Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday. Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday. Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Lisa Levin]

    Neovasc Inc (US) (NASDAQ: NVCN) shares were also up, gaining 71 percent to $0.880 following announcement of an agreement with Boston Scientific Corporation (NYSE: BSX).

Best Undervalued Stocks To Invest In 2018: Vanguard Short-Term Corporate Bond ETF(VCSH)

Advisors’ Opinion:


    For the details of SWISS RE LTD’s stock buys and sells, go to

    These are the top 5 holdings of SWISS RE LTDiShares Core S&P 500 (IVV) – 1,641,300 shares, 34.54% of the total portfolio. Shares added by 6.79%SPDR S&P 500 (SPY) – 1,003,200 shares, 20.97% of the total portfolio. Shares reduced by 34.15%iShares MSCI EAFE (EFA) – 2,800,100 shares, 15.78% of the total portfolio. Shares added by 170.34%iShares 1-3 Year Credit Bond ETF (CSJ) – 1,659,000 shares, 15.1% of the total portfolio. New PositionVanguard Short-Term Corporate Bond ETF (VCSH) – 937,000 shares, 6.48% of the total po

  • [By Todd Shriber, ETF Professor]

    and the Vanguard Short Term Corporate Bond ETF (NASDAQ: VCSH).

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

Best Undervalued Stocks To Invest In 2018: Retail Properties of America, Inc.(RPAI)

Advisors’ Opinion:

  • [By Ant贸nio Costa]

    Retail Properties of America Inc (NYSE: RPAI) has been in an impressive rebound since the lows of August and the stock price action continues to become Bullish. However, RPAI has run into the downtrend line resistance again and this could lead to a brief period of sideways consolidation or price correction from current levels. On watch.

Best Undervalued Stocks To Invest In 2018: Toro Company (The)(TTC)

Advisors’ Opinion:

  • [By Mitchell Clark]

     The Toro Company (NYSE:TTC) is one of my favorite small-caps for medium- to long-term investors. Selling specialized equipment for turf management and other industries, Toro is a proven winner that has provided very consistent growth in sales and earnings over the years.

    It’s not the fastest growing small-cap business, but it pays a decent dividend and has a loyal customer base in the golf course and contractor markets.

    Toro is now offering sprinkler refit equipment for water-starved jurisdictions like California. This company’s share price performance has been exemplary.


    In his “Homework” segment, Cramer followed up on a few stocks that had stumped him during earlier shows. He said that he’s taking a pass on Toro (TTC) , a stock that’s just off its highs and trades at a premium to rival Deere & Company (DE) .

Billion-Dollar Kik Taps $125 Million Token Offering To Energize User Base

NEW YORK, NY – Founder and CEO of Kik Ted Livingston speaks onstage during TechCrunch Disrupt NY 2016 at Brooklyn Cruise Terminal on May 11, 2016 in New York City. (Photo by Noam Galai/Getty Images for TechCrunch)

The creator of popular messaging platform Kik will test the prospects of crypto-based crowdfunding next month, when it begins an initial coin offering that seeks to raise a total of $125 million through the sale of a new Ethereum-based token.

Kik Interactive announced Tuesday its closed $50 million in funding from leading crypto investment firms Polychain Capital, Pantera Capital and Blockchain Capital. It aims to raise $75 million more when the token sale debuts on September 12. (Read more about Polychain Capital in our July cover story here.)

The move, which Founder and CEO Ted Livingston is lauding as the first mainstream adoption of cryptocurrency, allows Kik to remain independent in spite of reports of stunted user growth and dwindling cash. Kiks previous capital infusion came from Chinese internet and mobile giant Tencent, which invested $50 million in the Canadian startup back in August 2015 — earning Ontario-based Kik a $1 billion valuation, unicorn status.

The offering could more than double Kiks pre-ICO funding of $120.5 million raised since the firm’s inception in 2009.

Kin will fuel new experiences in communications, information, and commerce inside of Kik, and will also serve as a foundation for a new decentralized ecosystem of digital services, bringing a fair and sustainable business model to the market, Livingston said in a statement.

The 24-hour sale will comprise a total of 1 trillion Kin tokens, 488 billion of which were pre-sold at a 30% discount. The remaining tokens will be allocated among participants who register by September 9.

North Korea Making You Tense? How About Hurricane Harvey? Your Portfolio Will Survive


There are plenty of reasons to be concerned about the impact of geopolitical situations that are beyond our control: North Korea, Afghanistan, domestic and international terrorism. We now can add Hurricane Harveys economic impact to our list.  However, long-term damage to our portfolios shouldnt be one of our concerns.

Theres no denying that geopolitical events, such as a disruption in the supply of oil or an unanticipated regime change, can have an immediate impact on how the markets behave. However, the historical record shows that whatever effect geopolitical events have on the investing landscape, it tends to be relatively short-lived.

The only certainty is that portfolios will continue to fluctuate with headlines, and that there is no proven alternative to remaining committed to your long-term investment plan.  While it is paramount to understand current global events and their resulting impact on financial markets, it is of greater importance for investors to avoid shortsighted decisions rooted in angst and fear.

The Lehman Brothers bankruptcy in September 2008, which set off the worldwide financial crisis, disrupted the markets for a relatively long duration. It took the S&P 500 17 weeks to bottom out at 46% lower, and another 41weeks to climb back to its pre-bankruptcy level.  With reflection, The Great Recession, the worst market crash since 1929, required 14 months to recover.  This was certainly an extremely difficult period for investors, but still a relatively modest setback on most investors time horizon.  To my mind this period of recent history speaks volumes as to the resiliency of the markets, and the importance of maintaining a long-term perspective in the face of adversity.

Weve taken a look at market recovery times for other major events during the last 60 years, as shown in the chart below.

Clarfeld Financial Advisors

Markets Declines and Recoveries since WWII

Recent big-headline geopolitical events have likewise had short-lived effects on the markets. Despite all the noise from Brexit, the S&P lost 5.76% in the four days from peak to trough and was back to peak 11 days later.

Best Biotech Stocks To Buy Right Now

Related KERX Mid-Day Market Update: Conn's Drops Following Weak Q1 Results; Achaogen Shares Surge Mid-Morning Market Update: Markets Open Lower; Joy Global Profit Tops Expectations Keryx up 15% on disclosure of Klarman stake (Seeking Alpha) Related FOLD Amicus Therapeutics Gets European Commission Approval For Galafold in Patients With Fabry Disease Today's Top 10 Pre-Market Gainers Biotech Daily Digest: The Biotech Rally Continues; Another Small Cap Gets Bought Out; Icahn Targets Allergan (Seeking Alpha)

Toward the end of trading Thursday, the Dow traded up 0.18 percent to 17,821.51 while the NASDAQ climbed 0.21 percent to 4,962.80. The S&P also rose, gaining 0.16 percent to 2,102.65.

Leading and Lagging Sectors

Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).

Best Biotech Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Chris Dier-Scalise]

    On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

Best Biotech Stocks To Buy Right Now: ARIAD Pharmaceuticals Inc.(ARIA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares gained around 0.73 percent in trading on Monday. Meanwhile, top gainers in the sector included Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA), and VCA Inc (NASDAQ: WOOF).

Best Biotech Stocks To Buy Right Now: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Paul Ausick]

    ArQule Inc. (NASDAQ: ARQL) dropped about 23% Friday, to post a new 52-week low of $1.13 after closing at $1.47 on Thursday. The stock’s 52-week high is $2.17. Volume was about 15 times the daily average of around 150,000 shares. The biopharmaceutical company said this morning that a phase 3 trial of a cancer drug did not meet the primary endpoint of improving overall survival.

Best Biotech Stocks To Buy Right Now: Medivation Inc.(MDVN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process forMedivation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation’s board. Of the three biotech giants, Citigroup’s Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why:

  • [By Ben Levisohn]

    Well, it looks like Medivation (MDVN) now has five suitors after reports that Amgen (AMGN) is joining Pfizer (PFE), Sanofi (SNY), AstraZeneca (AZN) and Novartis (NVS) in considering a bid. Maxim’s Jason Kolbert and Jason McCarthy offer their thoughts:

    Medivation reports tonight at 4:30pm…

    We expect the focus to be on the recent proposals from Sanofi (SNY $38.75- NR); Pfizer (PFE $33.40 -NR), AstraZeneca (AZN $28.26-NR) and just today, Amgen (AMGN – $154.18 – NR)…

    Medivation is returning to new highs as suitors line up to make acquisition bids. In this scenario what is the right discount rate for modeling purposes?

    We believe our model for Xtandi revenues is good, therefore we review our risk rating and determine the following: 30% = $47 15% = $76 10% = $99

    With Medivation’s board having now said No to anything less than $65 per share, it suggests to us that the stability and predictability of Xtandi’s revenues is greater than we thought, the risk is lower. Our intermediate risk rating is 15% or $76 fair value.

    Shares of Medivation rose 0.3% to $59.22 today, while Pfizer gained 0.5% to $33.56, Sanofi fell 0.5% to $39.07, AstraZeneca dropped 0.6% to $39.07, Novartis declined 0.3% to $74.12, and Amgen ticked up 0.1% to $154.25.


  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

    PACCAR Inc (NASDAQ: PCAR) Aug16 52.5 Puts: 10000 @ ASK $1.70: 10k traded vs 335 OI: Earnings 7/26 $54.94 Ref Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Jul16 345 Puts: 949 @ ASK $8.70: 1003 traded vs 55 OI: Earnings 8/2 $360.20 Ref NVIDIA Corporation (NASDAQ: NVDA) Fri 6/24 47.0 Puts (Wkly) Sweep: 689 @ ASK $1.12: 3758 traded vs 136 OI: Earnings 8/4 $46.69 Ref Medivation Inc (NASDAQ: MDVN) Sep16 55.0 Puts: 4000 @ Above Ask! $3.40: 5303 traded vs 716 OI: Earnings 8/4 $59.44 Ref Expeditors International of Washington (NASDAQ: EXPD) Aug16 47.0 Puts Sweep: 950 @ ASK $1.35: 973 traded vs 381 OI: Earnings 8/2 $48.15 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

  • [By Lisa Levin]

    Shares of Medivation Inc (NASDAQ: MDVN) got a boost, shooting up 24 percent to $46.35 amid word of a new report from Bloomberg, saying the company is working with bankers to defend itself against preliminary interest of a takeover. However, Reuters separately reported the company is working with JPMorgan to handle interest from other companies, but said Medivation has no interest in selling itself.

Top China Stocks To Own For 2018

I track a number of metrics that can provide signals of potential economic and market troubles here in the U.S. Paying attention to these specific signals can help us as investors filter out all the other noise generated by the media—so we can make decisions about our investments only when it matters, and not beforehand. As news broke that one of my key metrics—the yield curve, which represents how much central banks are stimulating an economy—had flashed a trouble signal in China, I decided to apply my measures to the Chinese economy. As problems there can affect us here in the U.S., I wanted to see if China was really signaling an impending recession.


How the yield curve metric works

The yield curve is a graph of interest rates for different time periods. Briefly, in a normal economy, long-term rates should be higher than short-term rates. This is because a longer time period is inherently more uncertain, and investors should de mand a higher return to compensate for that uncertainty. Sometimes, though, short-term rates rise above longer-term ones, as investors get discouraged about longer-term opportunities at the same time as current troubles rise. This results in what is known as an inversion. As you might imagine, an inverted yield curve is usually a sign of trouble. I pay attention to this metric for just that reason.

Top China Stocks To Own For 2018: Inc.(NTES)

Advisors’ Opinion:

  • [By Joe Tenebruso]

    Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.

  • [By Sreekanth Anasa]

    Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.

Top China Stocks To Own For 2018: Clean Diesel Technologies Inc.(CDTI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is projected to post a quarterly loss at $0.18 per share on revenue of $10.25 million.

    Sphere 3D Corp. (NASDAQ: ANY) is estimated to post a quarterly loss at $0.11 per share on revenue of $22.10 million.

Top China Stocks To Own For 2018: Sina Corporation(SINA)

Advisors’ Opinion:

  • [By Ezra Schwarzbaum]

    It was quickly followed by two other Chinese social media sites: SINA Corp (NASDAQ: SINA) and Momo Inc (ADR) (NASDAQ: MOMO).

    Weibo Responds

    Weibo issued a press release later in the day saying it would cooperate with the State Administration of Press, Publication, Radio, Film and Television.

  • [By Shanthi Rexaline]

    SINA Corp (NASDAQ: SINA), which has a stake in Weibo, also tumbled.

    Weibo confirmed that the State Administration of Press, Publication, Radio, Film and Television of the People’s Republic of China or SAPPRFT has ordered local authorities to take measures to suspend audio and video services of some internet companies.

  • [By Steve Symington]

    Shares ofSINA Corporation(NASDAQ:SINA)rose 25.8% in 2016,according to data from S&P Global Market Intelligence, following a pair of stronger-than-expected quarterly reports from the Chinese internet leader in the second half.

  • [By Leo Sun]

    Warren Buffett famously told investors to be “fearful when others are greedy, and greedy when others are fearful.” Dedicated followers of that mantra would probably dismiss Chinese online media giant SINA (NASDAQ:SINA) — which rallied 120% over the past 12 months to a six-year high — as a “greedy” play.

Top China Stocks To Own For 2018: Euro/Yen(EJ)

Advisors’ Opinion:

  • [By Belinda Cao]

    E-House China Holdings Ltd. (EJ), a real estate brokerage, gained 9.2 percent to $9.70, extending it advance to a third week. Its American depositary receipts retreated 3.1 percent Sept. 20 from the highest level since May 2011.

Top China Stocks To Own For 2018: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) is estimated to report a quarterly loss at $0.04 per share on revenue of $256.05 million.

    America’s Car-Mart, Inc. (NASDAQ: CRMT) is projected to post its quarterly earnings at $0.58 per share on revenue of $149.13 million.

  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 9.76 percent to $1.35 in pre-market trading. ReneSola reported Q1 earnings of $0.06 per share on revenue of $260.7 million.

  • [By Monica Gerson]

    Wall Street expects ReneSola Ltd. (ADR) (NYSE: SOL) to report a quarterly loss at $0.04 per share on revenue of $256.05 million. ReneSola shares gained 2.50 percent to close at $1.23 on Friday.

Top China Stocks To Own For 2018: Baidu Inc.(BIDU)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Alphabet Inc being in a relatively steadyuptrend compared withsearch engine peerslike Yahoo! Inc (NASDAQ: YHOO), China basedBaidu Inc (NASDAQ: BIDU) and Russiafocused mid cap Yandex NV (NASDAQ: YNDX):

  • [By Leo Sun]

    In late February, Baidu’s (NASDAQ:BIDU) videostreaming subsidiary iQiyi raised $1.53 billion in fresh funds to compete more effectively with rival sites. Hillhouse Capital, IDG Capital, Sequoia Capital, and Baidu all purchased the newly issued convertible bonds, and Baidu disclosed that it had invested $300 million.

  • [By Leo Sun]

    Tech giant Baidu (NASDAQ:BIDU) owns China’s largest search engine and mapping platform, the popular video site iQiyi, and links it all together with a vast ecosystem of internet and cloud-based services.